drug eluting stents - Globe Thesis

Keyword [drug eluting stents] Result: 61 - 80 \| Page: 4 of 7
61.	Xience Prime Drug-Eluting Stents In The Treatment Of Coronary Heart Disease In The Appliaction Analysis Of The Effect
62.	Efficacy And Safety Of Short-term (≤6 Months) Duration Of Dual Antiplatelet Therapy After Second Generation Drug Eluting Stents:a Meta-Analysis Of Randomized Controlled Trials
63.	The Relationship Of RDW On The Long-term Survival Rate Of Patients Who Suffered NSTE-ACS And Got A Percutaneous DES Implantation
64.	Sirolimus Stents And Everolimus Stents For The Treatment Of Non St-elevation Acute Coronary Syndrome
65.	Intermediate-term Clinical Outcomes Of Coronary Heart Disease Treated By Everolimus-eluting Stent Or Rapamycin-eluting Stent
66.	Long-term Clinical Outcomes Of Everolimus Eluting-stents Compared To Sirolimus-Eluting Stents For The Treatment Of Coronary Heart Disease
67.	The Predictive Value Of Combined Clinical And Anatomical Factors For Long-term Prognosis In Patients With Coronary Heart Disease
68.	Comparison Of Postoperative Inflammatory Response Between Patients With Bioabsorbable Stents And Drug-eluting Stents
69.	The Outcome Of Percutaneous Coronary Intervention For Sever Atherosclerostic Lesions In Segment Proximal To Myocardial Bridge At Left Anterior Descending Coronary Artery
70.	In Vitro And Animals Experiments Of SZ-21/VEGF/RAPA Mulilayer-coating Stent
71.	The Efficacy And Safety Of Paclitaxel-coated Balloon In The Treatment Of Drug-eluting Stent In-stent Restenosis
72.	Association Of In-stent Restenosis With Patient Compliance After Drug-eluting Stent
73.	Effect Of Oversized Postdilatation Of Drug-Eluting Stents On Clinical Outcomes Of Patients With Coronary Atherosclerotic Disease
74.	Comparative Study Of Polymer Free And Biodegradable Polymer Drug Eluting Stents
75.	Drug-eluting Balloon Versus Second Generation Drug Eluting Stents In The Treatment Of In-stent Restenosis: Meta-analysis
76.	Efficacy Of Arsenic Trioxide Drug-eluting Stents In The Treatment Of Coronary Heart Disease
77.	Meta-analysis Of Drug-eluting And Bare-metal Stents For Treating The Patients With Chronic Kidney Disease And Coronary Artery Disease
78.	Retrospective Analysis Of Efficacy And Restenosis Rate Of Domestic Biodegradable And Non-biodegradable Polymer Drug-eluting Stents In The Treatment Of Coronary Artery Disease
79.	The Optimal Duration Of Dual Antiplatelet Therapy After Drug-eluting Stent Implantation
80.	Relationship Between Blood Lipid Management And In-stent Restenosis After Drug-eluting Stent Implantation In Patients With Coronary Heart Disease
<<First <Prev Next> Last>> Jump to